EnerSpar Corp.

• NurExone Biologic Inc. (ehemals Enerspar Corp.) meldet Abschluss des Reverse Takeover

  NurExone Biologic Inc. (ehemals EnerSpar Corp.) gab gestern bekannt, dass die zuvor angekündigte Transaktion mit NurExone Biologic Ltd. abgeschlossen wurde. Bei der Transaktion handelt es sich um eine "Reverse Takeover Transaction". Vorbehaltlich der endgültigen Genehmigung durch die TSX Venture Exchange rechnet das Unternehmen damit, dass die Stammaktien des Unternehmens in den nächsten Tagen den Handel an der Börse [...]

  weiterlesen

  16.06.2022

  von Redaktion
• EnerSpar meldet Notierung an Frankfurter Börse sowie Abschluss von Sommerarbeitsprogramm und bereitet sich für Herbstbohrungen vor

  EnerSpar freut sich, seine Notierung an der Frankfurter Börse unter dem Kürzel 5E0 bekannt zu geben. Der Marktmacher der Aktien des Unternehmens ist die Bankhaus Scheich Wertpapierspezialist AG. Das Unternehmen freut sich auch bekannt zu geben, dass IOS Services Géoscientifique Inc. aus Saguenay mit der Durchführung des Arbeitsprogramms im ersten Jahr beauftragt wurde, das in einem technischen Bericht gemäß National [...]

  weiterlesen

  14.09.2017

  von IRW-Press

weitere Meldungen

• NurExone Biologic Inc. (Formerly, Enerspar Corp.) Announces Completion of Reverse Takeover Transaction

  NurExone Biologic Inc. is pleased to announce that it has completed its previously announced business combination transaction with NurExone Biologic Ltd.. The Transaction is a "Reverse Takeover Transaction" as such term is defined under Policy 5.2 of the TSX-V. Subject to receiving final Exchange acceptance, the common shares in the capital of the Company are expected to resume trading on the Exchange in the next few [...]

  weiterlesen

  15.06.2022

  von Newsfile
• EnerSpar Corp. Announces Completion of Spin-Out

  EnerSpar Corp. is pleased to announce that further to its press releases of March 15, 2022 and May 12, 2022, the Company has completed its previously announced plan of arrangement. Pursuant to the Arrangement the Company has completed the spin out its wholly-owned subsidiary, 1222150 B.C. Ltd, by way of a dividend-in-kind distributing the securities of the SpinCo held by the Company pro rata to the shareholders of [...]

  weiterlesen

  01.06.2022

  von Newsfile
• EnerSpar and NurExone Announce Conditional Acceptance of Proposed Reverse Takeover Transaction

  EnerSpar Corp. and NurExone Biologic Ltd. are pleased to announce that the TSX Venture Exchange has conditionally accepted the previously announced reverse takeover transaction of EnerSpar pursuant to a securities exchange agreement dated as amended on January 3, 2022, and amending agreement dated April 12, 2022 with NurExone and its securityholders. The Proposed Transaction will constitute a reverse takeover of [...]

  weiterlesen

  18.05.2022

  von Newsfile
• EnerSpar Corp. Announces Distribution Date for Spin-Out Shares

  EnerSpar Corp. is pleased to announce that further to its press release of March 15, 2022, the Company has received court approval for its previously announced plan of arrangement. Pursuant to the Arrangement, the Company plans to spin out its wholly-owned subsidiary, 1222150 B.C. Ltd, by way of a dividend-in-kind distributing the securities of the Subsidiary held by the Company pro rata to the shareholders of the [...]

  weiterlesen

  13.05.2022

  von Newsfile
• EnerSpar Corp. Announces Closing of Private Placement of Subscription Receipts

  EnerSpar Corp. is pleased to announce that further to its press release of Jan 18, 2022, the Company has closed a non-brokered private placement through the issuance of 4,551,814 subscription receipts at a price of $0.80 per Subscription Receipt for aggregate gross proceeds of $3,641,451.20. The gross proceeds of the Offering are being held in escrow on behalf of the subscribers of the Subscription Receipts by Irwin [...]

  weiterlesen

  06.05.2022

  von Newsfile

weitere engl. Meldungen